To see, to know, to heal .    

Declare the past,
diagnose the present,
foretell the future (Hippocrates)

Seeing is the
beginning

Milestones
Research
About us
Career

photonamic

The name photonamic consists of photo (= light) and dynamics and thus represents the field of activity of photonamic GmbH & Co. KG ("photonamic"). The effect of light on certain molecules is manifold and ultimately leads not only to coloration, but can also lead to fluorescence or initiation of chemical reactions.
Photonamic takes advantage of these dynamics of light by using a specific molecule that is metabolized into a photosensitizer in cells or in cell assemblies or in the body. Depending on the choice of wavelength, this can lead to a wide variety of effects triggered by the light. The use of light and the application of photosensitizers is not really a new principle, but has been known and researched for decades.
photonamic has set itself the goal of researching and developing these possibilities in a targeted manner in order to derive diverse applications from them. Unlike many other approaches, the molecule primarily used by photonamic is a precursor of the actual photosensitizer, which is metabolically converted into the light-excitable molecule and exhibits the corresponding photodyna-mic properties. The resulting fascinating applications in imaging and also therapy form the core of photonamic's activities.
Through numerous collaborations and projects with partner companies, academic institutions for clinical applicability and also with corresponding equipment companies for light sources, sensors and camera systems, the diversity of these technologies can be imagined.

‍

TOP STORIES

‍

‍"US FDA Medical Device Registration of Aladuck405/II"

‍

SBI Pharmaceuticals Co., Ltd. (Head office: Minato-ku, Tokyo; Representative Director & President:Yoshitaka Kitao; hereinafter "SBIP"), a subsidiary company of SBI Holdings, Inc. which conductsresearch and development pharmaceuticals, etc., utilizing 5-aminolevulinic acid (*) announces todaythat the medical light source device "Aladuck405/II" (hereafter "Aladuck") marketed in Japan has beenregistered as a class II medical device with the U.S. FDA (Food and Drug Administration).

Prior to this, Aladuck has obtained "UL certification", one of the most recognized safety standards in the US electronics industry. In addition, Aladuck has obtained a conformity certificate "CB Report" byconducting safety tests on the device based on IEC (International Electrotechnical Commission) standards. These certifications have made it possible to obtain overseas certification easily andquickly.

Aladuck is a medical light source device that can be used in various surgical sites, as it can illuminate areas that are difficult to illuminate with conventional microscope light sources, and can be used together with a medical endoscope.SBIP will strive to fulfill Aladuck's worldwide needs and deliver them to wherever medical sites areneeded, both domestically and internationally.

‍

....more

‍

‍

‍

NEWS ARCHIVE

NutraIngredients-Awards granted for clinical study project with the food supplement 5-ALA + SFC as an immune system enhancer for COVID-19 vaccines

photonamic GmbH & Co KG (Photonamic) is pleased to announce that it's wholly-owned subsidiary SBI ALApromo GmbH, a company focused on the development of 5-ALA in various formulations as food .....

Photonamic GmbH & Co. KG (Germany) Enrolls First Patient in Phase 2 Clinical Trial


photonamic GmbH & Co. KG (Head office: Pinneberg, Germany; CEO: Ulrich Kosciessa, Ph.D.) ("photonamic"), a subsidiary of SBI Holdings, Inc. (Head office: Minato-ku, Tokyo; Representative Director, President and CEO: Yoshitaka Kitao) the leader in the pharmaceutical development, translation and global ....

Photonamic and Photonics Healthcare strengthen collaboration

photonamic GmbH & Co KG (Photonamic), a pharmaceutical company focused on the development of 5-aminolevulinic acid (5-ALA) in various applications, and Photonics Healthcare (Photonics), a medical technology company developing a novel technology for oxygen measurement in skin cells, announced that the two companies will further strengthen their strategic and ...

All press articles